Suspensions of maltose-grown cells of the hyperthermophilic archaeon Pyrococcus furiosus , when incubated at 90°C with 35 mM [1- 13 C]glucose or [3- 13 C]glucose, consumed glucose at a rate of about 10 nmol min −1 (mg protein) −1 . Acetate (10 mM), alanine (3 mM), CO 2 and H 2 were the fermentation products. The 13 C-labelling pattern in alamine and acetate were analyzed. With [1- 13 C]glucose the methyl group of both alanine and acetate was labelled; with [3- 13 C]glucose only the carboxyl group of alanine was labelled whereas acetate was unlabelled. Extracts of maltose-grown cells contained glucose isomerase (12.8 U mg −1 , 100°C), ketohexokinase (0.23 U mg −1 , 100°C), and fructose 1-phosphate aldolase (0.06 U mg −1, 100°C). Enzymes catalyzing the formation of fructose 1,6-bisphosphate from fructose 1-phosphate or fructose 6-phosphate could not be detected. As publihed previously by our group and other authors P. furiosus also contains enzymes of glyceraldehyde conversion to 2-phosphoglycerate according to a non-phosphorylated Entner-Doudoroff pathway, of dihydroxyacetone phosphate conversion to 2-phosphoglycerate according to the Embden-Meyerhof pathway, and of 2-phosphoglycerate conversion - via pyruvate - to acetate and alanine. Based on the enzyme activities in P. furiosus , the following pathway for glucose degradation to alanine and acetate in cell suspensions is proposed which can explain the [ 13 C]glucose labelling data: glucose→ fructose → fructose 1- phosphate → dihydroxyacetone phosphate + glyceraldehyde and further conversion of both trioses to alanine and acetate via pyruvate.
No takes yet. Share an insight, caveat, or question.
Schäfer et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: